Home > Insider Trading > Filing (0001104659-23-022971)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1933414	Mineralys Therapeutics Inc.	MLYS	()	E9

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1232258	Ltd. (Cayman) Investments Healthcare Hbm	Governors Square, Suite #4-212-2 23 Lime Tree Bay Ave., West Bay Grand Cayman E9 00000		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-02-14	1,941,368	$0.00	1,941,368	No	4	C	Direct
Common Stock	Acquisiton	2023-02-14	964,238	$0.00	2,905,606	No	4	C	Direct
Common Stock	Acquisiton	2023-02-14	312,500	$16.00	3,218,106	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2023-02-14	20,962,895	$0.00	1,941,368	$0.00
Common Stock	Series B Preferred Stock	Disposition	2023-02-14	10,411,846	$0.00	964,238	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

Upon the closing of the Issuer's initial public offering ("IPO"), each share of Series A Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into Common Stock. These shares of Series A Preferred Stock had no expiration date.
Upon the closing of the Issuer's IPO, each share of Series B Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into Common Stock. These shares of Series B Preferred Stock had no expiration date.